Filing Details
- Accession Number:
- 0001062993-23-023027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-21 16:04:33
- Reporting Period:
- 2023-12-19
- Accepted Time:
- 2023-12-21 16:04:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1116463 | Orasure Technologies Inc | OSUR | Surgical & Medical Instruments & Apparatus (3841) | 364370966 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1756089 | Gallagher Kathleen Weber | C/O Orasure Technologies, Inc. 220 East First Street Bethlehem PA 18015 | Chief Product Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-19 | 4,129 | $5.71 | 278,829 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-19 | 24,129 | $8.05 | 254,700 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2023-12-19 | 4,129 | $0.00 | 4,129 | $5.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-02-03 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Non-qualified stock options granted on February 3, 2014, vesting 25% at the end of 12 months after the grant date and 75% ratably on a monthly basis over the next 36 months. Vesting shall cease upon voluntary termination of employment.
Billionaire Hedge Funds
